Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Five-Year Multicenter Cohort Study of Vaginal Microbiome and STIs Progression

10 november 2026 uppdaterad av: Muxuan Chen, Shenzhen Maternity & Child Healthcare Hospital

A Five-Year Longitudinal Follow-Up Study on Vaginal Microbiome Characteristics and Their Association With Reproductive Tract STIs and Cervical Lesion Progression Based on a Multicenter Cohort

  1. To elucidate the long-term impact of vaginal microbiome and the dynamic trends of its characteristics across 5 years follow-up visits on the clinical outcomes of sexually transmitted infections (STIs).
  2. To determine the long-term effects of specific microbial infections (Up6, MH) and vaginal microbiome characteristics on the progression of STIs.

Studieöversikt

Status

Har inte rekryterat ännu

Betingelser

Detaljerad beskrivning

This multicenter, observational study is a 5-year longitudinal follow-up extending the CALM2004 cohort. It aims to enroll 7,574 women aged 18-60 to investigate the long-term impact of vaginal microbiome characteristics and sexually transmitted infections (STIs) on cervical lesion progression. By collecting vaginal secretions, and blood samples, the study will evaluate the 5-year cumulative incidence of CIN2+ and determine how specific microbial infections (e.g., Up6, MH) influence clinical outcomes, providing high-level evidence for cervical cancer prevention strategies.

Studietyp

Observationell

Inskrivning (Beräknad)

7574

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studieorter

    • Beijing Municipality
      • Beijing, Beijing Municipality, Kina
        • Peking University First Hospital
        • Kontakt:
          • Bingbing Xiao, Doctor
    • Fujian
      • Fuzhou, Fujian, Kina
        • Fujian Maternity and Child Health Hospital
    • Gansu
      • Lanzhou, Gansu, Kina
        • The First Hospital of Lanzhou University
        • Kontakt:
          • Haitao Yu, Doctor
      • Lanzhou, Gansu, Kina
        • Gansu Provincial Hospital
        • Kontakt:
          • Lianhua Wei, Doctor
    • Guangdong
      • Chaozhou, Guangdong, Kina
        • Chaozhou Central Hospital
        • Kontakt:
          • Fen lin, Doctor
      • Foshan, Guangdong, Kina
        • Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine
        • Kontakt:
          • Chaoxin Jiang, Doctor
      • Guangzhou, Guangdong, Kina
        • The First Affiliated Hospital, Sun Yat-sen University
        • Kontakt:
          • Bin Huang, Doctor
      • Guangzhou, Guangdong, Kina
        • Nanfang Hospital, Southern Medical University
        • Kontakt:
          • Dehua Sun, Doctor
      • Guangzhou, Guangdong, Kina
        • The Fifth Affiliated Hospital of Southern Medical University
        • Kontakt:
          • Xiaoyan Li, Doctor
      • Guangzhou, Guangdong, Kina
        • The First Affiliated Hospital of Guangzhou University of Chinese Medicine
        • Kontakt:
          • Yingchun Zhou, Doctor
      • Guangzhou, Guangdong, Kina
        • The Fifth Affiliated Hospital of Guangzhou Medical University
        • Kontakt:
          • Liang Peng, Doctor
      • Guangzhou, Guangdong, Kina
        • The Third Affiliated Hospital of Southern Medical University
        • Kontakt:
          • Xuefeng Wang, Doctor
      • Guangzhou, Guangdong, Kina
        • The Third Affiliated Hospital of Guangzhou University of Chinese Medicine
        • Kontakt:
          • Kewei Zhao, Doctor
      • Guangzhou, Guangdong, Kina
        • Zhujiang Hospital of Southern Medical University
      • Guangzhou, Guangdong, Kina
        • Guangzhou Baiyun District Taihe People's Hospital
      • Huizhou, Guangdong, Kina
        • Huizhou Municipal Central Hospital
        • Kontakt:
          • Xianjin Wu, Doctor
      • Shaoguan, Guangdong, Kina
        • Yuebei People's Hospital
        • Kontakt:
          • Pingsen Zhao, Doctor
      • Shenzhen, Guangdong, Kina, 518028
        • Shenzhen Maternity & Child Healthcare Hospital
        • Kontakt:
          • Yuting Dai
          • Telefonnummer: 0755-82869849
      • Shenzhen, Guangdong, Kina
        • Luohu District People's Hospital
      • Shenzhen, Guangdong, Kina
        • Southern Medical University Shenzhen Hospital
        • Kontakt:
          • Hongwei Zhou, Doctor
      • Shenzhen, Guangdong, Kina
        • The Seventh Affiliated Hospital, Sun Yat-sen University
        • Kontakt:
          • Zhaofan Luo, Doctor
      • Zhongshan, Guangdong, Kina
        • Zhongshan Xiaolan People's Hospital
        • Kontakt:
          • Wandang Wang, Doctor
      • Zhuhai, Guangdong, Kina
        • Zhuhai Maternal and Child Health Hospital
    • Guangxi
      • Nanning, Guangxi, Kina
        • The First Affiliated Hospital of Guangxi Medical University
        • Kontakt:
          • Faquan Lin, Doctor
    • Guizhou
      • Guiyang, Guizhou, Kina
        • Affiliated Hospital of Guizhou Medical University
        • Kontakt:
          • Fan Lu, Doctor
      • Zunyi, Guizhou, Kina
        • Zunyi First People's Hospital
        • Kontakt:
          • Kaifeng Wu, Doctor
    • Hainan
      • Haikou, Hainan, Kina
        • Hainan General Hospital
        • Kontakt:
          • Bo Wang, Doctor
    • Heilongjiang
      • Mudanjiang, Heilongjiang, Kina
        • Hongqi Hospital Affiliated to Mudanjiang Medical University
        • Kontakt:
          • Chunxia Guo, Doctor
      • Qiqihar, Heilongjiang, Kina
        • Qiqihar First Hospital
    • Henan
      • Zhengzhou, Henan, Kina
        • Henan Provincial People's Hospital
        • Kontakt:
          • Jing Zhao, Doctor
    • Inner Mongolia
      • Hohhot, Inner Mongolia, Kina
        • Inner Mongolia Autonomous Region Maternal and Child Health Hospital
        • Kontakt:
          • Jing Sha, Doctor
    • Jiangsu
      • Lianyungang, Jiangsu, Kina
        • The Second People's Hospital of Lianyungang
        • Kontakt:
          • Wei Liang, Doctor
    • Jilin
      • Jilin City, Jilin, Kina
        • Jilin City Central Hospital
        • Kontakt:
          • Guijie Zhang, Doctor
    • Liaoning
      • Shenyang, Liaoning, Kina
        • The First Hospital of China Medical University
        • Kontakt:
          • Ruizhe Wang, Doctor
    • Ningxia
      • Yinchuan, Ningxia, Kina
        • General Hospital of Ningxia Medical University
        • Kontakt:
          • Feng Li, Doctor
    • Qinghai
      • Xining, Qinghai, Kina
        • Qinghai Red Cross Hospital
        • Kontakt:
          • Dengyun Ma, Doctor
    • Shandong
      • Jinan, Shandong, Kina
        • Jinan Central Hospital
        • Kontakt:
          • Shuyi Han, Doctor
      • Jinan, Shandong, Kina
        • Shandong Provincial Hospital
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Kina
        • Shanghai East Hospital, Tongji University
        • Kontakt:
          • Jingxin Cheng, Doctor
    • Shanxi
      • Changzhi, Shanxi, Kina
        • Changzhi People's Hospital
        • Kontakt:
          • Guoxiang Zhang, Doctor
    • Sichuan
      • Dazhou, Sichuan, Kina
        • Dazhou Integrated Traditional Chinese and Western Medicine Hospital
        • Kontakt:
          • Xuesu He, Doctor
      • Luzhou, Sichuan, Kina
        • Affiliated Hospital of Southwest Medical University
        • Kontakt:
          • Jinbo Liu, Doctor
    • Tibet
      • Lhasa, Tibet, Kina
        • Tibet Autonomous Region People's Hospital

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 60 år (Vuxen)

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Kvinna

Testmetod

Icke-sannolikhetsprov

Studera befolkning

A total of 7,574 women aged 18-60 years who previously participated in the baseline of the CALM2004 multicenter cohort study will be recruited for this 5-year longitudinal follow-up. This is a multicenter study, and participants will be recruited through targeted invitations from the research team members. The study population consists of women with a broad spectrum of baseline vaginal microecological statuses and varying risks of STIs and cervical lesions.

Beskrivning

Inclusion Criteria:

  1. Female aged 18 to 60 years.
  2. Participants who previously participated in the baseline of the CALM2004 study.
  3. Volunteers who are recruited through targeted invitations and consent to participate in this study.

Exclusion Criteria:

  1. Pregnant women.
  2. Received treatment for reproductive tract infections or sexually transmitted infections (STIs) within the past month.
  3. Used broad-spectrum antibiotics, local genital probiotics, or vaginal suppositories within the past month.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Observationsmodeller: COHORT
  • Tidsperspektiv: PROSPECTIVE

Kohorter och interventioner

Grupp / Kohort
CALM2004 Follow-up Cohort

A total of 7,574 women aged 18-60 who previously participated in the CALM2004 baseline study will be enrolled for a 5-year longitudinal follow-up. Participants will undergo comprehensive assessments including questionnaires, vaginal secretion collection for metagenomic sequencing, cervical exfoliated cells for TCT and STI nucleic acid testing, and venous blood testing. No specific interventions will be administered.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Cumulative incidence of CIN2+ at 5 years
Tidsram: 5 years

The incidence rate of histologically confirmed Cervical Intraepithelial Neoplasia grade 2 or 3 (CIN2/3) or invasive cervical cancer occurring for the first time during the follow-up period, among participants who had no cervical lesions or were <CIN2 at baseline

5 years

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
New incidence and progression rates of ASC-US+ cytological abnormalities
Tidsram: 5 years

ASC-US+ new incidence: First occurrence of ASC-US or higher cytological abnormality during follow-up in participants with normal baseline cytology. ASC-US+ progression: First occurrence of LSIL/HSIL or higher cytological abnormality during follow-up in participants with baseline ASC-US. Cytology is evaluated according to the Bethesda System for Reporting Cervical Cytology.

5 years

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
HPV and STI incidence, clearance, and persistent/recurrent infection rates
Tidsram: 5 years

HPV new infection: baseline negative, follow-up positive; HPV clearance: baseline positive, follow-up negative; HPV persistent infection: same genotype positive at both baseline and follow-up. STI new infection: baseline negative, follow-up positive; STI clearance: baseline positive, follow-up same genotype negative; STI recurrent infection: same genotype positive at both baseline and follow-up.

5 years

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

20 december 2026

Primärt slutförande (Beräknad)

30 juni 2028

Avslutad studie (Beräknad)

30 december 2028

Studieregistreringsdatum

Först inskickad

10 november 2026

Först inskickad som uppfyllde QC-kriterierna

10 november 2026

Första postat (Faktisk)

17 november 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

17 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

10 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera